Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.

Starovasnik MA, Christinger HW, Wiesmann C, Champe MA, de Vos AM, Skelton NJ.

J Mol Biol. 1999 Oct 29;293(3):531-44.

PMID:
10543948
2.

Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.

Wiesmann C, Fuh G, Christinger HW, Eigenbrot C, Wells JA, de Vos AM.

Cell. 1997 Nov 28;91(5):695-704.

3.

Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.

Pan B, Li B, Russell SJ, Tom JY, Cochran AG, Fairbrother WJ.

J Mol Biol. 2002 Feb 22;316(3):769-87.

PMID:
11866530
4.

Crystal structure of the complex between VEGF and a receptor-blocking peptide.

Wiesmann C, Christinger HW, Cochran AG, Cunningham BC, Fairbrother WJ, Keenan CJ, Meng G, de Vos AM.

Biochemistry. 1998 Dec 22;37(51):17765-72.

PMID:
9922142
6.

Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.

Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G, Marmé D, Martiny-Baron G.

J Biol Chem. 1997 Apr 18;272(16):10382-8.

7.

Characterization of the VEGF binding site on the Flt-1 receptor.

Herley MT, Yu Y, Whitney RG, Sato JD.

Biochem Biophys Res Commun. 1999 Sep 7;262(3):731-8.

PMID:
10471394
8.

Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).

Tanaka K, Yamaguchi S, Sawano A, Shibuya M.

Jpn J Cancer Res. 1997 Sep;88(9):867-76.

PMID:
9369935
9.

1H, 13C, and 15N backbone assignment and secondary structure of the receptor-binding domain of vascular endothelial growth factor.

Fairbrother WJ, Champe MA, Christinger HW, Keyt BA, Starovasnik MA.

Protein Sci. 1997 Oct;6(10):2250-60.

11.
12.
14.

Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site.

Fairbrother WJ, Christinger HW, Cochran AG, Fuh G, Keenan CJ, Quan C, Shriver SK, Tom JY, Wells JA, Cunningham BC.

Biochemistry. 1998 Dec 22;37(51):17754-64.

PMID:
9922141
15.

Identification of the extracellular domains of Flt-1 that mediate ligand interactions.

Cunningham SA, Stephan CC, Arrate MP, Ayer KG, Brock TA.

Biochem Biophys Res Commun. 1997 Feb 24;231(3):596-9.

PMID:
9070853
18.
19.

Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity.

Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K, Aziz S, Cardona C, Hammond WP, Savidge GF, Rafii S, Sobel M.

Circ Res. 2002 Jul 12;91(1):25-31.

20.

Identification of the ligand-binding domain of human vascular-endothelial-growth-factor receptor Flt-1.

Ma L, Wang X, Zhang Z, Zhou X, Chen A, Yao L.

Biotechnol Appl Biochem. 2001 Dec;34(Pt 3):199-204. Erratum in: Biotechnol Appl Biochem. 2002 Jun;35(Pt 3):221.

PMID:
11730488

Supplemental Content

Support Center